Cetuximab Biosimilar - Anti-hEGFR mAb - Research Grade
Source
EMBL-EBI PDB-5iv2
Origin species
Human
Species
Mouse/Human
Expression system
Mammalian
Molecular weight
LC: 23kDa HC: 23kDa
Purity
>85%
Buffer
PBS pH7.5
Delivery condition
Blue ice (+4°C)
Delivery lead time in business days
3-5 days if in stock; 3-5 weeks if production needed
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
4°C for short term; -20°C for long term
Brand
ProteoGenix
Aliases /Synonyms
Cetuximab,Cetuximab,hEGFR,anti-hEGFR
Reference
PX-TA1019
Note
For research use only. Not suitable for human use.
Isotype
IgG1 Kappa
Clonality
Monoclonal Antibody
Description of Cetuximab Biosimilar - Anti-hEGFR mAb - Research Grade
General information about Cetuximab
Cetuximab is a chimeric (mouse/human) monoclonal antibody. It inhibits epidermal growth factor receptor (EGFR) and is used to treat metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. This product is for research use only.
Reviews
There are no reviews yet.